Surgery, Gastroenterology and Oncology
Vol. 20, No. 4, December 2015
Risk factors for acute kidney injury after liver transplantation
Dana Tomescu, Mihai Popescu, Simona Olimpia Dima, Vladislav Braşoveanu, Irinel Popescu
ORIGINAL PAPER, December 2015
Article DOI: 10.21614/jtmr-20-4-60
Introduction: Liver transplantation (LT) represents the only definitive treatment in End-Stage Liver Disease (ESLD). Patient outcome, including quality of life after LT depends on perioperative outcome and reduction of postoperative complications. Many studies identified acute kidney injury (AKI) as one of the most frequent complications after liver transplantation with a negative impact on both short and long term survival, and focused on identifying risk factors for AKI. Our aim is to assess modifiable risk factors in a single national center in a country that is stii under development in order to improve our clinical practice.

Methods: We collected retrospective data from 112 patients who underwent liver transplantation at Fundeni Clinical Institute, Bucharest between January 2012 and May 2013. Patients with acute liver failure and pre-existing renal dysfunction were excluded. Analyzed data were: demographic variables, severity of ESLD (assessed by severity scores and paraclinical variables) and co-morbidities, intraoperative blood loss and transfusion, intraoperative haemodynamics and vasopressor requirements, postoperative incidence of AKI and chronic kidney disease (CKD) and outcome (Post Anaesthesia Care Unit Length of Stay and mortality).

Results: The overall incidence of postoperative AKI was 35.77% (n=39) in the 109 patients included in the final analysis: AKI I (64.10% n=25), AKI II (23.07% n=9) and AKI III (12.83% n=5). Variables that correlated with AKI included: recipient age (p = 0.006), cardiovascular disease (p = 0.015), MELD-Na score (p=0.035), bilirubin (p=0.016), albumin (p=0.048). Univariate analysis identified intraoperative blood loss (p=0.010), Packed Red Blood Cells (RBC) (p=0.006) and Fresh Frozen Plasma (FFP) (p=0.001) transfusion and high-dose vasopressor support (p=0.034) as predictors of AKI. One year survival was significantly reduced in the 39 patients with AKI (79,5%) compared to patients without AKI in the early postoperative period (92,3%).

Conclusion: In conclusion, patients age, serum bilirubin and albumin levels, MELD-Na score, co-existing cardiovascular disease and intraoperative high vasopressor support represent risk factors for AKI after LT. Therefore, it is essential to early identify and correct if possible- these factors in order to increase the efficiency of therapeutic management of renal disease.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2318


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Mar 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/